LEXX Earnings

Quarterly EPS
$-2.07
Q4 2024
$-2.40
Q1 2025
$-2.25
Q2 2025
$-3.15
Q3 2025
$-2.07
Q4 2025
$-1.05
Q1 2026
$-0.90
Q2 2026
$-1.20
Q3 2026
Latest RevenueN/A
Latest Net Income-1992981
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$1.200-1992981-100.0%+61.9%
Q2 2026-$0.9020.0K-1452732-88.5%+60.0%
Q1 2026-$1.050-1597503-100.0%+56.3%
Q4 2025-$2.07174.0K-2697228+107.1%+0.0%
Q3 2025-$3.15174.0K-3790606+107.1%-61.5%
Q2 2025-$2.25174.0K-2716972+20.0%-150.0%
Q1 2025-$2.40183.9K-2706628+21.6%-23.1%
Q4 2024-$2.0784.0K-2186571+173.3%+9.6%
Q3 2024-$1.9584.0K-1784312
Q2 2024-$0.90145.0K-652733
Q1 2024-$1.95151.3K-1185038
Q4 2023-$2.2930.7K-1249015
Lexaria Bioscience (LEXX) — Earnings